Background-The extracellular matrix (ECM) plays an important role in the pathogenesis of atherosclerosis and in-stent restenosis. Elastin is an essential component of the ECM. ECM degradation can lead to plaque destabilization, whereas enhanced synthesis typically leads to vessel wall remodeling resulting in arterial stenosis or in-stent restenosis after stent implantation. The objective of this study was to demonstrate the feasibility of MRI of vascular remodeling using a novel elastin-binding contrast agent (BMS-753951). Methods and Results-Coronary injury was induced in 6 pigs by endothelial denudation and stent placement. At day 28, delayed-enhancement MRI coronary vessel wall imaging was performed before and after injection of gadoliniumdiethylene triamine pentaacetic acid (Gd-DTPA). Two days later, DE-MRI was repeated after administration of BMS-753951. Contrast-to-noise-ratio and areas of enhancement were determined. Delayed-enhancement MRI with BMS-753951 caused strong enhancement of the aortic, pulmonary artery, and injured coronary artery walls, whereas Gd-DTPA did not. Delayed-enhancement MRI of the stented coronary artery with BMS-753951 yielded a 3-fold higher contrast-to-noise-ratio when compared with the balloon-injured and control coronary artery (21Ϯ6 versus 7Ϯ3 versus 6Ϯ4; PϽ0.001). The area of enhancement correlated well with the area of remodeling obtained from histological data (R
tions, however, were limited by the use of nonspecific compounds, which rapidly extravasated into the vessel wall and enhanced areas with either increased distribution volume and delayed clearance (typically fibrosis) 13, 18 or increased endothelial permeability and neovascularization, 19, 20 thereby rendering meaningful clinical interpretation difficult. Conversely, the detection of specific biological processes involved in the initiation and progression of atherosclerosis such as inflammation, smooth muscle cell migration, apoptosis, and ECM remodeling could facilitate clinical data interpretation, enhance risk stratification, and provide a means for therapy control. Specifically monitoring ECM changes by contrast-enhanced MRI appears promising for the assessment of plaque burden in atherosclerosis or neointimal hyperplasia after angioplasty. 2, 7, 9 Because of the lack of an established large-animal model of coronary atherosclerosis and plaque rupture, we investigated a coronary injury model that we had developed and demonstrated previously with the use of MR lucent stents. 21 Similar to native atherosclerosis, this model is characterized by inflammation, cellular proliferation, and remodeling phases.
Using this model, we examined a novel elastin-specific, low-molecular-weight contrast agent (BMS-753951, Lantheus Medical Imaging, Billerica, MA) 22 for imaging vascular remodeling by MR. Herein, we demonstrate the feasibility of this approach in a swine model of endoluminal coronary injury through direct comparison of imaging observations to histomorphometric findings.
Methods

Animal Model and Vascular Injury
Coronary stenting of the left anterior descending coronary artery (LAD) and balloon injury of the left circumflex artery (LCX) were performed in 6 female Landrace pigs (weight, 30 to 35 kg). The right coronary artery (RCA) served as the control vessel. Stent placement was performed with a mean balloon pressure of 10 atm and a mean stent diameter of 3.5 mm. To prevent local signal void artifacts as typically observed with currently used stainless steel stents, lasered MR-lucent prototype stents (Aachen Resonance, Germany) composed of copper (75%), silver (8%), platinum (2%), gold (14%), and palladium (1%) 23 were used to allow artifact-free imaging of the stent lumen and vessel wall. Stent implantation was followed by a 28-day normal diet. All experimental procedures performed on animals were approved by the German legislation on protection of animals. Pigs were fasted for 12 hours with free access to water and then sedated with ketamine (10 to 15 mg/kg body wt), azaperone (2 mg/kg body wt), and atropine (0.5 to 1 mg/k body wt) by intramuscular injection. Animals were then intubated after an intravenous bolus of propofol 1% (3 to 5 mg/kg body wt) was given. General anesthesia with controlled positive-pressure ventilation was maintained with propofol 2% (8 mg/kg/h), and fentanyl was given as bolus every 30 minutes. Vital parameters including arterial invasive blood pressure, oxygen saturation, capnography, body temperature, and ECG were monitored throughout the entire experiment.
Elastin-Binding Contrast Agent
BMS-753951 (Lantheus Medical Imaging, North Billerica, MA) is a low-molecular-weight MR contrast agent with moderate specificity for elastin (IC 50 ϭ0.33 mmol/L) and similar blood half-life time to currently used extracellular Gd-based MR contrast agents (Ͻ2% ID/g after 60 minutes). It is composed of a gadolinium-diethylene triamine pentaacetic acid (Gd-DTPA) chelate, which is linked to the D-amino acid D-phenylalanine. Ex vivo and in vivo preclinical data demonstrate preferential uptake in the arterial wall with rapid clearance from the blood pool by renal excretion. Its relaxivity increases on binding to the arterial wall (4.5 mmol ⅐ L Ϫ1 ⅐ s
Ϫ1
(unbound) versus 13.7 mmol ⅐ L Ϫ1 ⅐ s Ϫ1 (bound to elastin), thereby increasing the target to background signal ratio. 22 
Specificity of BMS753951 for Elastin
Different studies were pursued to demonstrate specificity of BMS753951 for elastin. To determine the gadolinium distribution of BMS753951 within the vessel wall, electron microscopy of elastic lamina was performed. BMS-753951 spectra at various locations of aortic vessel wall samples (nϭ3) were acquired to generate a spatially resolved BMS-753951 maps. Similarly, a carbon map was generated to localize the elastic fibers in the aortic samples because elastin fibers are composed primarily of carbon. For this purpose, the aortic samples were prepared by cryofixation against a liquid nitrogen cooled metal block. Cryosections were cut at Ϫ120°C, transferred to Pioloform-coated Ni-grids, and freeze-dried over night. The sections were coated with a thin layer of carbon and viewed and analyzed in a FEI-Tecnai-12-electron microscope equipped with an EDAXEDS detector. Mapping was achieved with Edax software (EDAX, Cambs, UK).
Second, inductively coupled mass spectroscopy (ICP-MS) was performed on a subset of stented vessels (nϭ2) and control coronary segments (nϭ2) to quantify the amount of BMS753951 accumulation in the vessel wall. Vessel samples were digested in 70% nitric acid at 37°C overnight, followed by dilution with deionized water for ICP-MS analysis. A standard curve was run with each sample set for Gd concentration determination. In addition, Elastica van Gieson (elastin) staining was performed in the stented, control, and ballooninjured coronary segments to visually assess elastin content.
Last, in vitro binding of BMS753951 to elastin was compared with other proteins as follows: [
153 Gd]BMS753951 was incubated with 5 mg/mL purified elastin from bovine cartilage or 5 mg/mL bovine serum albumin or 10 mg/mL of extracellular matrix protein chondroitin-6-sulfate. 
MRI Protocol
At day 28 after injury, free-breathing ECG-triggered coronary MR angiography (MRA) 24 and delayed gadolinium enhancement (LGE) imaging 25 of the coronary vessel walls were performed using a 1.5-T MR scanner (Achieva, Philips Medical Systems, Veldhofen, The Netherlands) before and after injection of 0.2 mmol/kg Gd-DTPA (Magnevist, Bayer-Schering Health Care, Berlin). Animals were imaged in the supine position using a 5-element, cardiac phasedarray coil and an advanced cardiac software package (R 2 , 1.3). After localization of the heart and determination of the mid-to end-diastolic rest period, a fast coronary scout scan was performed for identification of the course of the 3 major coronary arteries for subsequent high resolution coronary MRA and delayed enhancement coronary vessel wall imaging. Imaging parameters of the freebreathing-ECG-triggered and navigator (NAV)-gated inversion recovery segmented gradient echo vessel wall sequence targeted along the LAD, LCX, and RCA included field of viewϭ320 mm, matrixϭ256ϫ256, in-plane-resolutionϭ1.25ϫ1.25 mm, slicethicknessϭ3 mm, acquisition windowϭ50 ms, TR/TEϭ4.7 ms/1.4 ms, flip angleϭ30°, and slicesϭ24. The inversion time for nulling blood signal was determined using a Look-Locker sequence acquired in a coronal view of the heart. Data acquisition was synchronized with the mid-to end-diastolic quiescent phase of coronary motion, and navigator gating was performed using an end-expiratory 5-mm gating window. Two days later, coronary MRA and delayed BMS-753951 enhancement (LBE) coronary vessel wall imaging were repeated before and 30, 60, 90, and 120 minutes after injection of 0.1 mmol/kg BMS-753951. 22 
X-Ray
After completion of MRI, x-ray coronary angiography was performed to assess the degree of luminal stenosis in the stented and balloon-injured vessel segment. Subsequently, the animals were euthanized, and hearts were harvested for histological analysis.
Image Analysis
For objective image analysis, contrast-to-noise-ratio (CNR) between vessel wall and blood was determined by manual segmentation of the aortic and coronary vessel wall in the stented, balloon-injured, and control vessels on reformatted images. CNR was determined 30, 60, 90, and 120 minutes after contrast agent administration. For improved simultaneous visualization of focal contrast agent uptake and coronary anatomy, coronary MRAs were manually registered and overlaid with the delayed-enhancement images, thereby providing fused images similar to image fusion performed in positron-emission computed tomography (CT)/CT.
Both the combined intimaϩmedia volume (volume intimaϩmedia ϭ 2ϫstent-length/[3ϫ(area stent prox ϩ2ϫarea stent mid ϩarea stent dist ϩsqrt [area stent prox ϫarea stent mid ]ϩsqrt(area stent mid ϫarea stent dist )]) of the stented vessel wall and the combined intimaϩmedia area from histology were assessed. Areas of late enhancement detected by LBE-MRI were manually segmented in each slice, and the volume was calculated by multiplication with the slice thickness. Combined media and intima volume were only assessed in the stented vessel wall because only in those segments, significant enhancement allowed for reliable manual contouring.
Histopathology and Histomorphometry
The coronary arteries were deep-frozen or fixed in formalin immediately after explantation. Elastica-van Gieson staining was performed in stented, control, and balloon-injured coronary segments to assess remodeling of the extracellular matrix. Elastin appears black on Elastica-van Gieson staining.
The combined mean intima-media area was assessed in 3 slices, the proximal, mid, and distal slices of the stented vessel segment and in 1 representative slice for the balloon injured and control vessel.
Because the severity of vessel injury by stenting strongly correlates with neointimal thickness and percent diameter stenosis, 26 -29 the mean injury score for each section was measured as described by Schwartz et al 27 : 0ϭno injury; 1ϭbreak in the internal elastic lamina by stent strut; 2ϭperforation of the media by stent strut; and 3ϭperforation of the external elastic lamina by stent strut.
Statistics
Results are expressed as meanϮSD. A Student t test (unpaired, 2-tailed) as applied for the comparison of continuous variables and a probability value of Ͻ0.05 was considered statistically significant.
Results
Binding of BMS753951 to Elastin
Previous studies indicate that [
153 Gd]BMS753951 binds to elastin. 22 This was examined further by electron microscopy, inductively coupled mass-spectroscopy (ICP-MS), and examining the binding of [
153 Gd]BMS753951 to purified elastin, serum albumin, and of chondroitin-6-sulfate, another extracellular matrix protein.
Electron microscopy showed an excellent colocalization of targeted gadolinium [
153 Gd]BMS753951 with elastic fibers and the carbon map, because elastin fibers are composed primarily of carbon ( Figure 2 ). With ICP-MS, a strong increase in Gd concentration in stented coronary vessel segments (50 to 100 mol/L) was observed compared with normal noninjured segments (10 mol/L). In addition, in vitro binding studies showed that [
153 Gd]BMS753951 preferentially binds to elastin compared with the other 2 proteins (Figure 1) .
These results are in good agreement with DE-MRI ( Figures  3, 4 , 5, and 6) and histological data ( Figures 5 and 6) , showing increased elastin accumulation in the neointima of the stented vessel compared with the balloon-injured and control vessel segments.
MRI of Coronary Vessel Wall and Histological Data
All animals were scanned without any adverse events. Strong aortic and pulmonary artery wall delayed enhancement (LBE) was seen after BMS-753951 administration (Figures 3, 5 , and 6), which is in agreement with the high elastin content in those elastic vessels, whereas no visually apparent delayed enhancement (LGE) was observed after Gd DTPA injection (PϽ0.001). BMS-753951 spectra at various locations of an aortic vessel wall sample were acquired to generate a spatially resolved BMS-753951 map (C). Similarly, a carbon (B) map was generated to localize the elastic fibers in the aortic sample. Elastin fibers are composed primarily of carbon. A transmission electron microscopy image (A) of the aorta shows the course of one elastic fiber (white arrow, black box). Good colocalization between BMS-753951 distribution (C), carbon, and elastic fibers can be observed (white arrows).
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In addition, after administration of BMS-753951, strong delayed enhancement (LBE) of the stented coronary vessel segment (Figures 3 through 5 ) and intermediate to little enhancement of the balloon-injured ( Figure 6 ) coronary vessel segment were observed. There was little to no visually apparent delayed enhancement in the control coronary artery apart from enhancement of the very proximal parts of both the RCA and left main coronary artery ( Figure 6 ). No delayed enhancement of the stented, balloon-injured, and control coronary vessel segments was observed on native inversion recovery images (Figure 3 ). After administration of Gd-DTPA delayed enhancement (LGE), coronary wall imaging showed little to no visually apparent enhancement in the injured vessel wall (stent or angioplasty) (Figures 3  and 4) and no visually apparent enhancement in the control vessel.
Histological analysis revealed severe vascular remodeling in the stented segments ( Figure 5 and Figure 7) , with a mean injury score similar to other studies, where comparable arterial injury correlated with a considerable increase in neointima hyperplasia. 26, 27 The injury score also showed comparable stent expansion in all stented arteries (Table) . In addition, only minor remodeling in the balloon-injured segments in all animals was documented ( Figure 6 ). This observation is consistent with the visual appearance of strong BMS-753951 delayed enhancement (LBE) in the stented coronary wall segments and intermediate to little delayed enhancement (LBE) in the balloon-injured coronary wall segments (Figures 3, 5, and 6) . A good correlation was found between the combined media and intima volume by LBE-MRI and histology with a slight overestimation of 27% by MRI (Figure 7) .
Quantitative analysis of vessel wall enhancement after administration of BMS-753951 yielded a 3-fold higher CNR (Figure 8 ) in the stented coronary artery when compared with the balloon-injured and control arteries (PϽ0.05). No significant difference between the balloon-injured vessel and the control vessel was found. In addition, CNR between the vessel wall and coronary blood was 3-fold increased in the stented coronary artery segment when compared with precontrast images approximately 30 minutes after BMS-753951 administration and remained at a consistently high level in the stented coronary vessel wall segment, suggesting strong association with the vessel wall with no washout tendency up to 2 hours after BMS-753951 injection (Figure 8 ). Planimetric evaluation of the combined media and intima areas in the stented (proximal, mid, and distal slices), balloon-injured, and control vessels (representative slices) correlated well with the CNR in those segments as measured by delayed-enhancement MRI using BMS-753951 (Figure 8 ).
X-Ray Coronary Angiography
Conventional x-ray single-plane coronary angiography revealed no significant stenoses in the injured vessel segments in 5 animals. Only 1 animal showed a single 25% to 50% diameter in-stent stenosis in the LAD.
Discussion
This study demonstrates that MRI with BMS-753951, an elastin-specific contrast agent, leads to signal enhancement in 
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areas of severe vessel wall injury due to an increase in the combined media and intima area, whereas no such findings were observed with conventional extracellular Gd-DTPA. The very low uptake of Gd-DTPA in normal and injured coronary vessel segments also suggests that the observed signal enhancement with BMS-753951 probably is not related to a distribution volume effect as typically seen for Gd-DTPA but rather related to specific binding. This observation was also confirmed by electron microscopy, ICP-MS, and the binding experiments to purified elastin. Delayedenhancement MRI with BMS-753951 showed significantly higher signal enhancement in the stented coronary segment compared with the balloon-injured and control arteries; areas of enhancement were in good agreement with the increase in combined intima-media area as measured by histology. Histological analysis revealed considerable vascular remodeling in the stented segments and only minor remodeling in the balloon-injured segments. Furthermore, we observed strong uptake of BMS-753951 in the vessel wall of elastic arteries (no venous enhancement) with no washout tendency up to 2 Morphometric variables with the mean injury score and the mean neointima area in stented arteries are shown. Histomorphometric analysis of animal 5 revealed a chronic total coronary artery occlusion (CTO), which did not allow defining an injury score.
*Injury score was defined as follows: 0ϭno injury; 1ϭbreak in the internal elastic lamina by stent strut; 2ϭperforation of the media by stent strut; and 3ϭperforation of the external elastic lamina by stent strut.
hours after administration of the contrast agent. This novel approach may be useful for in vivo monitoring of vascular remodeling after mechanical injury. Additional studies with this approach are required to demonstrate the assessment of vessel wall thickness (plaque burden) in patients with suspected coronary artery disease (CAD). In addition, enhancement of elastic arteries such as the aorta and the pulmonary arteries was observed, whereas little uptake was found in native muscular arteries such as the control coronary artery segments.
ECM formation is the principal mechanism of restenosis in various experimental models and in humans after balloon angioplasty or stent placement 6, 30, 31 and also contributes to the pathogenesis of atherosclerosis. 3, 5, 6 Previous studies have shown that elastin is an important component of this process. [7] [8] [9] Specifically, Brasselet et al 7 have demonstrated that inhibition of elastin cross-linking resulted in a decrease in constrictive remodeling, and consequently, restenosis, after arterial injury. Otherwise, elastin content is markedly increased after arterial injury. 9 Moreover, in the study of Nili et al, 9 collagen and elastin were major contributors to ECM synthesis after 21 and 60 days after injury, in which the accumulation of elastin was attributed to an increased sensitivity to the mechanical forces of blood flow or balloon distension. Krettek et al 8 documented an ongoing but often ineffective elastogenesis in human atherosclerotic disease. Hence, the measurement of cumulative elastin content by MRI may be a promising technique for detection and quantification of ECM synthesis during arterial remodeling.
Noninvasive coronary vessel wall imaging by MRI has already been demonstrated in pilot studies for in vivo risk stratification through quantification of subclinical coronary atherosclerotic plaque burden and outward arterial remodeling related to nonsignificant CAD. [13] [14] [15] 32 However, a targetspecific contrast agent for exclusive in vivo imaging of arterial remodeling would allow improved sensitivity and specificity for assessing processes directly associated with vessel wall repair or compensatory remodeling in atherosclerosis. In this regard, the present study demonstrated that noninvasive imaging of elastin formation by coronary MRI using an elastin-specific contrast agent is feasible and may be useful for noninvasive assessment of arterial remodeling after vascular injury. The finding of increased BMS-753951 uptake after coronary vessel wall injury by LBE-MRI correlated well with the area of remodeling obtained from histological data. A good correlation between the volume of remodeling by histology and the volume of delayed enhancement was found in the stented vessel wall, with MRI slightly overestimating (27%) the intima-media volume. This overestimation probably results from the limited spatial resolution of the data sets as shown by Schar et al. 33 Taken together, contrast-enhanced coronary vessel wallimaging by MR may be a promising technique for diagnosis of early inward or outward remodeling after mechanical injury. Further studies are required to evaluate the pertinence of these findings in patients with multiple cardiac risk factors and a high likelihood of subclinical or advanced atherosclerosis.
Comparison With Other Imaging Techniques
Although x-ray angiography and multidetector CT (MDCT) provide excellent spatial resolution and morphological details in a fraction of time required for coronary MRI, they have low sensitivity for contrast agent detection and therefore are limited in their ability to detect biological alterations in the vascular wall. Nevertheless, MDCT has been shown to provide valuable information about certain plaque components (soft, fibrous, calcified plaque) 34 and information on vessel wall remodeling in patients with documented CAD. 35 It remains to be seen whether MDCT, especially with the advent of dual-energy MDCT or multispectral CT, will play a major role in the biological characterization of the vascular wall in the future.
Limitations
Coronary in-stent stenosis cannot be directly assessed by MRI because of the local signal void caused by susceptibility induced background gradients or radiofrequency shielding of currently used stainless steel stents. 36 In our experimental setting, we used an MR-lucent prototype stent to allow artifact-free imaging of the stent lumen and vessel wall. Hence, at present, this technique is not feasible in a clinical setting.
Because our model did not produce significant in-stent stenosis as demonstrated by x-ray, signal enhancement was mainly related to positive remodeling of the stented area. The sensitivity for minor remodeling is limited by spatial resolu- Figure 7 , we only quantified the area of remodeling by contrast-enhanced MRI for the stented segments, in which significant signal enhancement could be observed. In addition, we used an animal model without underlying atherosclerosis. Thus, results obtained in this study may differ from patients with advanced CAD. Furthermore, elastin is present in both the pathologically altered and normal vessel walls of highly elastic vessels such as the aorta and the pulmonary arteries and thus further studies are required to better understand the clinical meaning of the observed increase in elastin signal in patients with subclinical and advanced CAD with and without intervention.
The circumflex coronary artery is sometimes more difficult to image with MRI because of its posterior location and the resulting lower CNR. This may have caused a slightly lower CNR in the balloon-injured vessel when compared with the stented LAD, but it is unlikely to explain a 3-fold lower CNR as measured in this study.
Because this novel contrast agent binds to both normal and immature de novo (tropo)elastin (synthesized as a response to vessel injury), the observed signal enhancement after BMS-753951 administration depends on the natural variability of mature elastin fibers in the coronary arteries. In this study, we observed a significantly and consistently higher CNR in the stented vessel segment (CNR Ϸ20) when compared with the control and balloon-injured vessel segments (CNR Ϸ5 to 7), suggesting de novo (tropo)elastin formation in the stented vessel segments as also demonstrated by histology. However, distinguishing newly formed (tropo)elastin from mature elastin is not feasible with this method. Finally, the contrast agent used in this study is not approved for clinical application at the present time.
Conclusions
We demonstrate the feasibility of noninvasive assessment of vascular remodeling in an animal model of coronary vessel wall injury using a novel, low-molecular-weight, elastinbinding gadolinium chelate and MR-lucent stents. The presented technique may have applications for the detection of pathological alterations of the ECM in patients with subclinical and advanced CAD. Further studies systematically relating elastin to enhanced MRI following BMS-753951 administration in nonatherosclerotic and atherosclerotic animal models and degenerative ECM disease are now warranted.
